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The crystal structure of the NADH-dependent bacte-
rial flavoenzyme morphinone reductase (MR) has been
determined at 2.2-Å resolution in complex with the oxi-
dizing substrate codeinone. The structure reveals a di-
meric enzyme comprising two 8-fold / barrel domains,
each bound to FMN, and a subunit folding topology and
mode of flavin-binding similar to that found in Old Yel-
low Enzyme (OYE) and pentaerythritol tetranitrate
(PETN) reductase. The subunit interface of MR is
formed by interactions from an N-terminal  strand and
helices 2 and 8 of the barrel domain and is different to
that seen in OYE. The active site structures of MR, OYE,
and PETN reductase are highly conserved reflecting the
ability of these enzymes to catalyze “generic” reactions
such as the reduction of 2-cyclohexenone. A region of
polypeptide presumed to define the reducing coenzyme
specificity is identified by comparison of the MR struc-
ture (NADH-dependent) with that of PETN reductase
(NADPH-dependent). The active site acid identified in
OYE (Tyr-196) and conserved in PETN reductase (Tyr-
186) is replaced by Cys-191 in MR. Mutagenesis studies
have established that Cys-191 does not act as a crucial
acid in the mechanism of reduction of the olefinic bond
found in 2-cyclohexenone and codeinone.
The flavoenzyme morphinone reductase (MR)1 from Pseudo-
monas putida is a member of the Old Yellow Enzyme (OYE)
family of proteins (1). MR catalyzes the NADH-dependent sat-
uration of the carbon-carbon bond of both morphinone and
codeinone. The products of these reactions, hydromorphone
and hydrocodone, are valuable semi-synthetic opiate drugs;
hydromorphone is a powerful analgesic (seven times more po-
tent than morphine (2)), and hydrocodone is a mild analgesic
and antitussive (3). The synthesis of both compounds is com-
plicated owing to difficulty in specifically oxidizing the C-6
hydroxy group of morphine and the often limiting supply of
thebaine (a precursor for the synthesis of hydrocodone). These
shortcomings have led to the development of novel recombinant
biocatalytic routes for hydromorphone and hydrocodone syn-
thesis (4). Biological synthesis exploits the ability of Esche-
richia coli, transformed with the genes encoding morphinone
reductase and morphine dehydrogenase and fed with morphine
or codeine, to accumulate hydromorphone and hydrocodone,
respectively (5, 6).
MR is a dimeric flavoenzyme of Mr 82,200 (1). It contains one
molar equivalent of non-covalently bound FMN per enzyme
subunit, and based on sequence similarity studies it belongs to
the Class I flavin-dependent / barrel oxidoreductases (1, 7).
The Class I subfamily includes the isoforms of OYE (8), estro-
gen binding protein (EBP) from Candida albicans (9), pentae-
rythritol tetranitrate (PETN) reductase (10), glycerol trinitrate
reductase (11), the xenobiotic reductases of Pseudomonas spe-
cies (12), and 12-oxophytodienoic acid reductase from tomato
(13) and Arabidopsis thaliana (14). MR is also related to the
more complex bile acid-inducible flavoenzymes Bai H and Bai C
(15), the bacterial Fe/S flavoenzymes tri- and dimethylamine
dehydrogenases (16, 17), and the NADH oxidase of Thermo-
anaerobium brockii (18). These latter enzymes utilize diverse
substrates, but the catalytic framework has clearly evolved
from a common progenitor (7).
The crystallographic structures of three members of the
Class I subfamily of / flavin oxidoreductases have been re-
ported, including that of the complex iron-sulfur flavoprotein
trimethylamine dehydrogenase (19, 20). The structures of OYE
and a number of ligand complexes of OYE have been reported
(21), although the physiological substrate of the enzyme re-
mains elusive. More recently, we reported structures of PETN
reductase and complexes of PETN reductase with steroid in-
hibitors and substrates (22). The folds of both OYE and PETN
reductase comprise an 8-fold / barrel and reveal the presence
of FMN bound at the C-terminal ends of the internal -strands.
The active sites are highly conserved, which reflects the ability
of OYE and PETN reductase to reduce the unsaturated bond of
a number of 2-cyclic enones (23, 24). Additionally, PETN re-
ductase has been shown to catalyze the denitration of nitro-
ester explosives, the reduction of nitroaromatic explosives such
as trinitrotoluene and picrate and degradation of the nitramine
explosives (Royal Demolition Explosive (RDX)) (25, 26).
MR shares with the other Class I subfamily members the
ability to reduce a number of 2-cyclic enones and to form
complexes with steroids (27). However, MR is distinct in its
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ability to reduce the unsaturated carbon-carbon bond of a num-
ber of opiate compounds (27). Sequence alignment studies also
suggest differences in the chemical nature of the active site of
MR compared with OYE and PETN reductase (1). To investi-
gate these aspects, and to provide a structural basis for de-
tailed mechanistic studies of MR, we have solved the structure
of MR in complex with the opiate substrate codeinone at 2.2-Å
resolution. The structure is discussed in the context of the
mechanism of opiate reduction and in view of the existing
structural information for PETN reductase and OYE.
EXPERIMENTAL PROCEDURES
Materials—All materials were of analytical grade. Codeinone was a
gift from MacFarlan Smith (Edinburgh, Scotland). Mimetic Yellow 2
FIG. 1. A, structure of a single subunit of MR illustrating the location of the N-terminal cap (-strands A and B) and the polypeptide excursion
incorporating -strands C and D located between -helix 3 and -strand 3 of the barrel core. The location of the FMN cofactor is shown at the
C-terminal end of the barrel domain in ball-and-stick format. B, an orthogonal view of the overall structure of MR illustrating the interactions
between the two subunits. Subunit interactions formed by residues in helices 1, 2, and 8 and the external  strands A and B are shown. The
graphics image was produced using MOLSCRIPT (46).
TABLE I
Data collection and refinement statistics for crystals of MR reductase and its complex with codeinone
Values for the outer shells of data are shown in parentheses. For the final model, the parameters are Rwork (Rfree), 20.5% (21.6%); number of
protein atoms (including FMN), 2917 (390 waters); average B factors for protein atoms, 26.9 Å2; root mean square deviations from ideal bond
lengths, 0.01 Å; root mean square deviations from ideal bond angles, 1.3 °.
Dataset Cu RAXIS IIc SRS 7.2 MAR180 Cu RAXIS IV
Wavelength (Å) 1.5418 1.488 1.5418
Total reflections 134,821 47,854 73,745
Unique reflections 18,992 20,305 23,548
Cell (Å) 49.6, 121.7, 178.2 47.83, 121.44, 177.78 49.52, 121.34, 178.22
Resolution (Å) 2.5 (2.59) 2.36 (2.44) 2.2 (2.14)
Completeness (%) 99 (97) 91.3 (67.3) 85.1 (69.4)
Rmerge (%), outer shell 9.2, 24.2 5.7, 24.4 6.3, 29.2
T/ (T) 26.4 (8.5) 13.7 (3.7) 11.9 (3.1)
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affinity chromatography resin was from Affinity Chromatography Ltd.
Q-Sepharose resin was from Amersham Biosciences.
Protein Purification and Mutagenesis—MR was purified from a re-
combinant strain of E. coli expressing the enzyme from the cloned mor
B gene as described previously (27) but also incorporating a final chro-
matographic step using Q-Sepharose. In this latter step, enzyme was
applied to a Q-Sepharose column (8.5 cm  5 cm) equilibrated with 30
mM Tris buffer, pH 8.0, containing 2 mM 2-mercaptoethanol (buffer B).
The column was washed with 2 liters of buffer B containing 230 mM
NaCl and the enzyme was eluted using a gradient of NaCl (250–500
mM) contained in buffer B. For long term storage, MR was kept at
80 °C in 50 mM potassium phosphate buffer, pH 7.0. The C191A
mutant MR was isolated using the QuikChange mutagenesis protocol
(Stratagene) and the following oligonucleotides: 5-GTC CAC GCC GCC
AAC GCC GCG CTG CCC AAC CAG TTC CTC-3 and 5-GAG GAA
CTG GTT GGG CAG CGC GGC GTT GGC GGC GTG GAC-3. Plasmid
pMORB3 (1) was used as template for the mutagenesis reactions. The
mutant gene was completely sequenced to ensure that spurious changes
had not arisen during the mutagenesis reaction. Expression and puri-
fication of the C191A MR enzyme was as described for wild-type
enzyme.
Crystal Growth—Initial crystallization conditions for the enzyme
have been described elsewhere (28), but conditions were refined in the
course of the work described here. The optimum crystals were grown
from 15–25% monomethyl polyethylene glycol 550, 0.1 M HEPES, 0.1 M
NaCl, 1 mM dithiothreitol, pH 6.5–7.5, using the sitting-drop vapor
diffusion method. Crystals of the codeinone-enzyme complex were iso-
lated by soaking the crystals in a solution comprising 1 mM codeinone,
10 mM phosphate buffer, and 30% monomethyl polyethylene glycol at
pH 6.2 for 20 min. The crystals could be flash-frozen directly, and data
were collected in the home laboratory. The crystals belong to space
group I212121 with cell dimensions a  49.9Å, b  121.7 Å, and c 
178.2 Å and contain one molecule per asymmetric unit.
X-ray Data Collection—Data sets were obtained from single crystals
mounted in rayon loops and cooled to 173 °C in a gas stream of N2.
Three sets of data were used in the course of the work described here.
The original data (2.5 Å) were collected using a RAXIS IIc image plate
device mounted on a Rigaku rotating anode source with MSC/Yale
mirrors. Subsequent 2.36-Å data were recorded at Station 7.2 of SRS
(Synchrotron Radiation Source) Daresbury Laboratory with an MAR
180 image plate device, and final 2.2-Å data were recorded using a
RAXIS IV image plate device mounted on a Rigaku rotating anode
source with MSC/Yale mirrors. Data were processed and reduced using
DENZO and SCALEPACK (29). Data statistics are presented in Table
I. A random 5% set of the possible reduced data was selected and used
to flag reflections for the calculation of free R values (30) in all data sets.
Structure Solution and Refinement—The structure was solved by
molecular replacement using AMoRe (31) with a model based on OYE
(Protein Data Bank code 1OYA) (21). The correct solutions to the
rotation function had the highest peaks with a correlation coefficient of
14.8l; the next highest peaks had a value of 9.5. The translation func-
tion solution gave a coefficient of 29.1; this increased to a value of 40.2
upon rigid-body refinement (R 49.4% for data in the range 20–4.0 Å).
The starting model was made using the sequence alignment of French
et al. (10); all non-conserved side chains were truncated to alanine or
glycine ,and all insertions in the OYE sequence were deleted. FMN was
not included in these molecular replacement calculations, but calcula-
tion of difference maps showed clear density for the cofactor, confirming
that the correct solution had been chosen. Subsequent refinement was
carried out with XPLOR version 3.843 (32). The model was broken into
12 segments (determined by secondary structure), and each segment
was refined as a rigid body. Inspection of sigmaA (33) and Fo  Fc maps
was performed with XTALVIEW (34), and rebuilding was followed by
simulated annealing and positional refinement. Further rounds of re-
building and refinement reduced R (Rfree) for the data for 20–2.5 Å to
36.1% (38.0%) with 80 water molecules. The 2.36-Å data were collected
from a crystal soaked with codeinone, and refinement was continued
using CNS 0.5 (32). This included further rounds of rebuilding and
refinement (both positional and temperature-factor) resulting in a
model with R (Rfree) for data for 40–2.36 Å of 24.5% (28.1%). No
interpretable density was seen in the active site, and further codeinone
soaking steps were tried. The final 2.2-Å data were collected with a
crystal soaked as described above. Refinement with these data used
CNS 1.0 (32) and gave final values for R and Rfree of 20.5% and 21.6%.
Codeinone was built into difference density using atomic parameters
extracted from the Cambridge Structural Data base through the Chem-
ical Data base Service at Daresbury Laboratory. The parameters for
refinement were calculated with XPLOR2D (35). Refinement statistics
and final model parameters are presented in Table I. The 2.2-Å data
and coordinate files have been deposited with the Protein Data Bank
(accession code 1GWJ).
Kinetic Studies—All kinetic studies were performed under strict
anaerobic conditions (5 ppm of O2) within a glove box environment
(Belle Technology) to prevent oxidase activity of MR. Steady-state as-
says were performed using a Jasco V530 spectrophotometer at 25 °C.
Reaction buffer was 50 mM potassium phosphate, pH 7.0, which was
made anaerobic by bubbling with humidified Pureshield argon at
5 p.s.i. for 2 h prior to introduction into the glove box. NADH solutions
were made from pre-weighed powder and anaerobic buffer inside the
glove box, and the concentration was determined spectrophotometri-
cally (340  6220 M
1 cm1). Solutions of 2-cyclohexenone were made
by dilution of a stock (10 M) into anaerobic buffer. The initial velocity in
steady-state assays was determined from absorbance changes at 340
nm in a reaction cell volume of 1 ml; the desired concentration of
substrate and cofactor solutions was achieved by making microliter
additions to the cell. Least squares fitting procedures to the standard
Michaelis-Menten equation were performed using Origin (v6) software
(Microcal).
Stopped-flow kinetic experiments were performed under anaerobic
conditions using an Applied Photophysics SX.17MV stopped-flow in-
strument, and transients were analyzed using non-linear least squares
regression using Spectrakinetics software (Applied Photophysics). Av-
erages of five to seven individual transients were analyzed. The enzyme
was contained in 50 mM potassium phosphate buffer, pH 7.0. In the
reductive half-reaction, enzyme (20 M) was mixed with NADH at
different concentrations (at least 5-fold the enzyme concentration to
ensure pseudo-first order conditions). Flavin reduction was monitored
at 462 nm; formation and decay of the enzyme-NADH charge-transfer
FIG. 2. Active site structure of MR and protein-flavin interac-
tions in MR. A, superposition of the active sites of MR, OYE, and
PETN reductase. The numbering of residues is according to that for
MR. Asn-189 and His-186 are equivalent to Asn-194 and His-191 of
OYE, which are known to be involved in the binding of ligands in the
active site of OYE. In PETN reductase the equivalent residue to Asn-
189 of MR is a histidine. In OYE and PETN reductase Cys-191 is
replaced by tyrosine; this latter group is known to be a proton donor in
OYE. Acetate is shown bound to PETN reductase as seen in the crys-
tallographic structure of this enzyme (22). Colors used are: OYE, yellow;
MR, magenta; PETN reductase, cyan. B, amino acid residues in direct
contact with the FMN in MR.
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species was monitored at 552 nm (36). In studies of the oxidative
half-reaction, MR was titrated with sodium dithionite to produce the
2-electron-reduced form of MR. Reduced MR (20 M) was then mixed
with 2-cyclohexenone at different concentrations, and flavin oxidation
was monitored at 462 nm. Equations used to analyze the reductive
half-reaction have been described elsewhere (36). Analysis of the tran-
sients obtained for the oxidative half-reaction is described under
“Results.”
RESULTS AND DISCUSSION
Overall Structure—The structure of MR was determined at
2.2-Å resolution by molecular replacement using OYE as the
search model. The structure reveals an 8-fold / barrel with
non-covalently bound FMN located toward the center and
C-terminal end of the barrel (Fig. 1A). The overall subunit
structure is similar to that reported for OYE (21) and PETN
reductase (22). However, it is closer to PETN reductase in that
it has a -loop excursion (comprising of residues 131–151)
between  strand 3 and -helix 3 of the core barrel domain
instead of the helix found in OYE. Additionally, -strands A
and B form a cap at the N-terminal domain of the barrel, as
seen also in OYE (21) and PETN reductase (22). MR is di-
meric, and the structure of the dimer (Fig. 1B) reveals that
the subunit interactions are different from those reported for
OYE (21). In OYE, the dimer interface involves helices 4, 5,
and 6 of the / barrel, but in MR the interface is less
extensive and comprises interactions between the N-terminal
 strands (strands A and B, Fig. 1B) and helices 2 and 8 of the
barrel domain. The dimer interface in MR is not part of the
highly conserved region identified by Fox and Karplus in
their analysis of OYE (21). In addition, in MR the C-terminal
excursion of one subunit extends over the dimer interface and
interacts with the corresponding extension from the second
subunit (Fig. 1B). This C-terminal extension also partially
FIG. 3. Kinetic transients and plots of rate versus coenzyme concentration for the reductive half-reactions of wild-type and C191A
MR. Conditions: 50 mM potassium phosphate buffer, pH 7.0; 283 K. A, transient observed for the C191A mutant MR at 550 nm; NADH
concentration 200 M. B, transient observed at 462 nm for the C191A mutant MR; NADH concentration 200 M. Similar transients were obtained
for wild-type MR, and examples of these can be found in our previous paper (36). C, plot of observed rate versus NADH concentration for the
wild-type enzyme. Filled circles, observed rate for formation of the NADH-enzyme charge-transfer species; unfilled circles, observed rate for flavin
reduction. D, same as for panel C, but for C191A MR.
TABLE II
Apparent kinetic parameters determined from steady-state assays of wild-type and C191A mutant MR enzymes
Fixed substrate
Wild-type C191A
App. Km App. kcat App. Km App. kcat
mM s1 mM s1
NADH (150 M)a 4.2  0.2 0.80  0.01 8.5  0.4 0.32  0.01
2-cyclohexen-1-one (40 mM)b 8.9  0.6 0.88  0.01 12.5  0.9 0.34  0.02
a Apparent kinetic parameters are for 2-cyclohexen-1-one.
b Apparent kinetic parameters are for NADH.
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defines the entrance to the active site of MR along with the
polypeptide excursion found between  strand 3 and -helix 3
of the core barrel domain.
Active Site Structure in Relation to Other Members of the
OYE Family—The active site structure of MR is presented in
Fig. 2A, alongside those for OYE and PETN reductase. Impor-
tant differences in the active site of MR can be discerned.
Tyr-196 in OYE is known to function as an active site acid in
the oxidative half-reaction with / unsaturated enones (37).
This residue is conserved in PETN reductase (Tyr-186), but in
MR the equivalent residue is Cys-191. The active site of MR is
larger than the corresponding site in OYE. This is primarily
due to the presence of a largely hydrophobic insertion (residues
Arg-291 to Glu-301) in OYE that is absent in MR, which lines
FIG. 4. Kinetic transients and plots of rate versus 2-cyclohexenone concentration for the oxidative half-reactions of wild-type and
C191A MR. Conditions: 50 mM potassium phosphate buffer, pH 7.0; 283 K. A, transient observed for wild-type MR at 462 nm; 2-cyclohexenone
concentration 2 mM. B, transient observed for the C191A mutant MR at 462 nm; 2-cyclohexenone concentration 2 mM. C, plot of observed rate (fast
phase) versus concentration of 2-cyclohexenone. The solid line is the fit to the rapid equilibrium formalism of Strickland et al. (45); the lack of an
intercept on the ordinate axis illustrates the absence of a reverse reaction. D, same as for Panel C but for C191A mutant MR. See text for kinetic
parameters determined from the fitting processes.
SCHEME 1
SCHEME 2
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the entrance to the active site close to the dimethylbenzene
subnucleus of the flavin isoalloxazine ring. Wider access to the
active site no doubt reflects the ability of MR to bind more
bulky and conformationally restrained substrates such as co-
deinone and morphinone. His-191 and Asn-194 in OYE, which
are involved in ligand binding (21, 38), are conserved in MR as
His-186 and Asn-189.
The nature of the flavin contacts in MR (Fig. 2B) are essen-
tially identical to those described for OYE, except the O3 atom
of the ribityl hydroxyl group is H-bonded to Asn-275 in MR,
whereas in OYE this interaction is absent. A key interaction
with the flavin is that made by residue Arg-238. The side chain
of this group is located close to the N-1/C-2 carbonyl region of
the flavin isoalloxazine ring, where it is expected that negative
charge will develop during enzyme reduction. Although the
positioning of a positively charged side chain in this region in
many flavoproteins has been postulated to stabilize developing
negative charge (and thus facilitate flavin reduction), our re-
cent mutagenesis studies with MR indicate that Arg-238 is not
required to stabilize the reduced flavin (39). This finding is in
stark contrast to similar work on lactate monooxygenase,
where mutation of the positively charged residue at this region
(Lys-266 to Met-266) impairs flavin reduction by substrate (40).
NADH is the natural coenzyme preference of MR. In con-
trast, PETN reductase, like OYE, has a strong preference for
NADPH. The mode of binding NADPH in OYE is not clear;
crystallographic studies with the NADP analogue (c-THN)TPN
show changes in electron density, but more than one interpre-
tation for the ADP portion has been presented (21). In the
absence of a model for coenzyme binding, it is difficult to
account for the differences in coenzyme specificity between the
family members. Preference for NADPH is often conferred by
the presence of two arginine residues in the vicinity of the
2-phosphate group of the coenzyme (41, 42), although it is
important to note that these preferences are derived from a
different protein fold. In NADH-dependent dehydrogenases
these arginine residues are absent, and an acidic residue (as-
partate or glutamate) forms a hydrogen bond to the 2-hydroxy
group of NADH (41, 42). In searching for residues that confer
coenzyme preference in the OYE family, we note from modeling
studies in which the NMN (nicotinamide mononucleotide) por-
tion of the coenzyme adopts a conformation similar to that seen
in OYE (21) that the polypeptide excursion between -strand 3
and -helix 3 of the core barrel domain might be positioned
appropriately to form interactions with the distal part of the
coenzyme. In PETN reductase two arginine residues (Arg-142
and Arg-130) are candidates to confer specificity for NADPH.
In contrast, in the NADH-dependent MR these residues are
absent and an acidic residue (Glu-135 for MR) is present. We
suggest this region of the protein might be important in con-
FIG. 5. Transients obtained for the oxidation of wild-type and C191A MR by codeinone. Conditions: 50 mM potassium phosphate buffer,
pH 7.0; 283 K. A, kinetic transient observed at 650 nm for the reaction of NADH-reduced wild-type MR with codeinone (2 mM); fast rate (increase
in absorption), 608 s1, slow rate (decrease in absorption), 119 s1. B, same as for Panel A but for C191A MR; fast rate (increase in absorption),
490 s1, slow rate (decrease in absorption), 40 s1. C, kinetic transient observed at 462 nm for the reaction of reduced wild-type MR with codeinone
(2 mM); fast rate (absorption increase), 104 s1; slow rate (absorption increase), 15 s1. D, same as for Panel C but for C191A MR; fast rate
(absorption increase), 29 s1; slow rate (absorption increase), 4 s1.
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ferring coenzyme specificity. In OYE, however, the polypeptide
excursion between -strand 3 and -helix 3 is replaced by a
-helix. If our proposed site for coenzyme recognition is correct,
then the mode of interaction of the coenzyme in this region of
OYE is different from that in PETN reductase and MR, making
general conclusions concerning coenzyme recognition in the
family difficult. However, there are a number of acidic and
basic residues in this region of OYE that could form interac-
tions with the reducing coenzyme in OYE. Our future studies
are now focused on defining those residues that interact with
NADH by mutagenesis and kinetic methods.
Crystal Soak Experiments—We have made a number of at-
tempts to soak ligands into the active site of crystalline MR.
Our studies have included soaking steps with NADH and the
oxidizing substrates 2-cyclohexenone and codeinone. Upon
soaking crystals with NADH, the yellow appearance of the
crystals fades indicating reduction of the enzyme-bound FMN.
This reduction of the flavin occurs without crystal cracking, but
analysis of frozen crystals showed no evidence for the presence
of coenzyme in the active site. Our observations suggest that
NADP and NADPH have relatively low affinities for reduced
enzyme, consistent with a ping-pong reaction mechanism (27)
and with the known moderate affinity of reduced OYE for
NADP (43). Similarly, analysis of crystals soaked with 2-cy-
clohexenone showed no evidence of ligand binding in the active
site. In contrast, we have had some limited success in analysis
of crystals soaked with the oxidizing substrate codeinone. The
active site of the MR-codeinone complex clearly shows a large
peak of electron density that is not seen in the absence of
codeinone. The density is difficult to interpret unambiguously
and suggests that codeinone binds in more than one orienta-
tion. The density is located over the si-face of the flavin in a
region similar to that seen with ligands of PETN reductase (22)
and OYE (21). Possible interpretations of the density for co-
deinone are included in the header of the Protein Data Bank
entry.
Properties of the C191A Mutant Enzyme—Inspection of the
active site of MR and comparison with the active site structures
of OYE and PETN reductase reveals that the conventional
active site acid (Tyr-196 in OYE and Tyr-186 in PETN reduc-
tase) is absent in MR. A common feature of these enzymes is
their ability to reduce the olefinic bond of 2-cyclohexenone. The
crystal structure of PETN reductase solved in the presence of
2-cyclohexenone reveals that Tyr-186 is ideally placed to pro-
tonate the substrate following reduction of the olefinic bond by
hydride transfer from the flavin N5 (26) (Fig. 3A). Mutagenesis
of Tyr-196 in OYE has also confirmed that this residue donates
a proton to 2-cyclohexenone in the oxidative half-reaction (37).
Given that MR also catalyzes the reduction of the olefinic bond
in 2-cyclohexenone, we were interested to learn if Cys-191 (the
equivalent of Tyr-196 in OYE and Tyr-186 in PETN reductase)
could serve as a proton donor in the reduction of 2-cyclohex-
enone and codeinone.
Apparent kinetic parameters determined under steady-state
conditions using 2-cyclohexenone as oxidizing substrate for
both the wild-type and C191A MR enzymes are displayed in
Table II. The C191A mutant enzyme retains the ability to
reduce 2-cyclohexenone, suggesting that Cys-191 does not play
a major role in catalysis. The most pronounced effect on the
steady-state kinetic parameters is 	2.5-fold reduction in ap-
parent kcat on converting Cys-191 to alanine. We investigated
the kinetics of the reductive and oxidative half-reactions of the
wild-type and C191A enzymes to ascertain if the reduction in
apparent kcat is associated with impaired flavin reduction or
oxidation. Detailed studies of the reductive half-reaction of
wild-type MR with NADH as reducing substrate have been
reported elsewhere (36) at 278 K, but corresponding studies of
the oxidative half-reaction using 2-cyclohexenone as substrate
were not reported. Herein, we report the kinetic behavior of
both the C191A and wild-type enzyme with NADH, 2-cyclohex-
enone, and codeinone (determined at 283 K).
The kinetic scheme for the reductive half-reaction is shown
in Scheme 1. The minimal kinetic scheme (Scheme 1) is slightly
modified compared with that presented in Craig et al. (36)
(Scheme 2) in that an additional enzyme-NADH complex is
shown prior to formation of the enzyme-NADH charge-transfer
complex. Inclusion of this complex is consistent with work on
OYE (43) and EBP (44), although direct evidence for its forma-
tion was lacking in our previous studies with wild-type MR
(36). However, our studies with C191A MR suggest that such a
species might exist prior to formation of the charge-transfer
species (see below). Kinetic transients for flavin reduction and
formation of the enzyme-NADH charge-transfer intermediate
and plots of observed rate as a function of NADH concentration
are shown in Fig. 3 for wild-type and C191A MR. As reported
previously for wild-type MR, the rate of formation of the char-
ge-transfer species (observed at 552 nm) is linearly dependent
on NADH concentration, whereas the observed rate for flavin
reduction is independent of NADH concentration in the range
125–675 M. The observed rates of flavin reduction for wild-
type and C191A MR enzymes are essentially identical (22 and
21 s1, respectively). The second order rate constant for forma-
tion of the charge-transfer species with C191A MR (6.2 0.1
105 M1 s1) is approximately one-half the value measured for
wild-type MR (12.3  0.4  105 M1 s1). For Scheme 2, the
value of the positive intercept of the ordinate axis (29  14 and
93 8 s1 for wild-type and C191A, respectively) approximates
to k2  k1. Additionally, the observed rate of flavin reduction
(	20 s1 for both enzymes) is independent of NADH concen-
tration (Fig. 3). An approximate value of 9 and 70 s1 for k1
can therefore be estimated for wild-type and C191A, respec-
tively. This gives rise to values of 	7 and 	113 M, respec-
tively, for the enzyme-NADPH dissociation constant in wild-
type and C191A MR. For the wild-type enzyme, the lack of a
concentration dependence on the flavin reduction rate in the
range 125–675 M is therefore consistent with Scheme 2 and a
dissociation constant for the charge-transfer complex of 7 M.
However, the elevated dissociation constant for the C191A
mutant is inconsistent with Scheme 2, because one expects a
concentration effect on the flavin reduction rate at relatively
low NADH concentrations. The lack of such concentration de-
pendence would be consistent with the more complex Scheme 1,
which has been shown for the MR-related enzymes OYE and
EBP. Our data for C191A is therefore more consistent with a
scheme (Scheme 1) in which a NADH-enzyme complex accu-
mulates prior to formation of the charge-transfer intermediate,
where the formation of this complex is rapid (occurring in the
dead-time of the stopped-flow apparatus). On the basis of the
above arguments it would seem plausible that the same rapid
formation of a NADH-enzyme complex prior to formation of the
charge-transfer species also occurs in wild-type MR. In this
regard, it is important to note that Scheme 1 is not inconsistent
with the observed kinetic behavior seen for wild-type MR.
The kinetic behavior of the oxidative half-reaction was in-
vestigated using 2-cyclohexenone as oxidizing substrate by
mixing with MR that had been reduced at the 2-electron level
with dithionite. Recovery of the flavin absorption was observed
at 462 nm, and transients were found to be biphasic (Fig. 4).
The fast phase contributed 90% of the total amplitude
change. Fitting to a standard biphasic expression revealed that
the observed rate for this phase was dependent on 2-cyclohex-
enone concentration, and data were analyzed by fitting to the
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rapid equilibrium formalism of Strickland et al. (45) (Fig. 4).
The observed rate for the slow phase (0.02 and 0.01 s1 for the
wild-type and C191A mutant enzymes, respectively) was inde-
pendent of 2-cyclohexenone concentration, and the origin of
this relatively small absorbance change is uncertain. Analysis
of the fast phases for the wild-type and C191A MR enzymes
using the Strickland equation yielded limiting rate constants of
0.9 0.02 and 0.32 0.01 s1, respectively. The corresponding
dissociation constants for the reduced enzyme-2-cyclohexenone
complex are 5.7  0.5 and 11.7  0.9 mM, respectively. The
values of the limiting rate constants for flavin oxidation are
similar to the apparent kcat values measured under steady-
state reactions (Table II). The stopped-flow data indicate,
therefore, that flavin oxidation is rate-limiting in steady-state
turnover and that mutation of Cys-191 leads to a reduction in
kcat by compromising the rate of hydride transfer from the
flavin N5 to the olefinic bond of 2-cyclohexenone.
Owing to the very limited supplies of codeinone and difficul-
ties encountered with its stability under stopped-flow condi-
tions, we were unable to conduct an extensive study of the
concentration dependence of the oxidative half-reaction with
this substrate. However, we were able to collect a small number
of kinetic transients for enzyme oxidation by codeinone. Fig. 5
illustrates kinetic transients obtained by mixing 2-electron-
reduced MR (i.e. enzyme reduced with a stoichiometric concen-
tration of NADH) with codeinone (2 mM). At 650 nm, a charge-
transfer species accumulates prior to hydride transfer to
codeinone (consistent with our previous work with wild-type
MR (36)) for both wild-type and C191A MR. The formation of
the charge-transfer species occurs with similar kinetics in both
enzymes (608 and 490 s1 for wild-type and C191A, respective-
ly). Flavin re-oxidation observed at 462 nm gives rise to bipha-
sic transients; the rates of both phases are 	4-fold less in
C191A MR, but it is important to emphasize that these are not
limiting rate constants. The transients indicate, however, that
mutation of Cys-191 does not substantially impair the oxida-
tive half-reaction when codeinone is used as the oxidizing sub-
strate. Reactions with codeinone are faster than with 2-cyclo-
hexenone by a factor of about 103, suggesting that the olefinic
bond of codeinone is more optimally aligned with the flavin N5
atom in reduced enzyme compared with the olefinic bond in
2-cyclohexenone. Our data rule out the possibility that Cys-191
acts as a crucial active site acid in the mechanism of reduction
of 2-cyclohexenone and codeinone. The identity of the key acid
will be explored in future studies by mutagenesis and kinetic
studies.
Concluding Remarks—At the subunit level, the structure
of MR reveals a close structural similarity with OYE and
PETN reductase, but the interactions that direct subunit-
subunit association are fundamentally different from those
reported for OYE. Comparison of the structures of PETN
reductase (NADPH-specific) and MR (NADH-specific) sug-
gest a region located in a polypeptide excursion between
-strand 3 and -helix 3 of the core barrel domain that might
confer specificity for the reducing coenzyme. Superposition of
the structure of MR with that of OYE and PETN reductase
reveals a high degree of conservation within the active site,
reflecting the ability of this family of enzymes to reduce
“generic” substrates such as 2-cyclohexenone. The active site
acid (Tyr-196 and Tyr-186 in OYE and PETN reductase,
respectively) is not conserved in MR and is replaced by Cys-
191. Mutagenesis studies reveal that Cys-191 does not play a
crucial role in the reductive or oxidative half-reactions of MR,
thus ruling out a key role as an acid in the reduction of
olefinic substrates. A number of alternative potential resi-
dues in the active site of MR may serve as the crucial active
site acid required for reduction of the olefinic bond in
2-cyclohexenone and codeinone.
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